131 related articles for article (PubMed ID: 2878298)
1. Recurrent parotitis with H2 receptor antagonists.
Caraman P; Netter P; Semin-Cosson AM; Parrot B; Trechot P; Azoulay E
Lancet; 1986 Dec 20-27; 2(8521-22):1455-6. PubMed ID: 2878298
[No Abstract] [Full Text] [Related]
2. Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
Tomasko MA; Luskin AT
Am J Med; 1988 Aug; 85(2):271. PubMed ID: 2899973
[No Abstract] [Full Text] [Related]
3. [Side-effects of H2-receptor antagonists].
Thuesen B; Knigge U; Christiansen PM
Ugeskr Laeger; 1986 May; 148(20):1191-5. PubMed ID: 2873670
[No Abstract] [Full Text] [Related]
4. [Exacerbation of psoriasis during treatment with H2 antagonists].
Andersen M
Ugeskr Laeger; 1991 Jan; 153(2):132. PubMed ID: 1671185
[No Abstract] [Full Text] [Related]
5. Omeprazole, H2 blockers, and polyarthralgia: case-control study.
Meier CR; Jick H
BMJ; 1997 Nov; 315(7118):1283. PubMed ID: 9390057
[No Abstract] [Full Text] [Related]
6. Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status.
Andersen M; Schou JS
Pharmacol Toxicol; 1991 Oct; 69(4):253-8. PubMed ID: 1683484
[TBL] [Abstract][Full Text] [Related]
7. IgE-mediated drug fever due to histamine H2-receptor blockers.
Hiraide A; Yoshioka T; Ohshima S
Drug Saf; 1990; 5(6):455-7. PubMed ID: 1981005
[TBL] [Abstract][Full Text] [Related]
8. Famotidine and ranitidine, but not cimetidine, cause severe, disabling headache.
Hirsch E
Am J Gastroenterol; 1989 Feb; 84(2):202-3. PubMed ID: 2563629
[No Abstract] [Full Text] [Related]
9. Histamine-2 receptor antagonists and gastric cancer.
Johnson AG; Jick SS; Perera DR; Jick H
Epidemiology; 1996 Jul; 7(4):434-6. PubMed ID: 8793372
[TBL] [Abstract][Full Text] [Related]
10. [Hemolytic anemia and thrombocytopenia induced by cimetidine: recurrence with ranitidine administration].
Takimoto R; Mogi Y; Kura T; Niitsu Y
Rinsho Ketsueki; 1997 Feb; 38(2):124-8. PubMed ID: 9059066
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular adverse effects of H2-receptor antagonists].
Hinrichsen H; Kirch W
Dtsch Med Wochenschr; 1994 Apr; 119(14):525-30. PubMed ID: 7908870
[No Abstract] [Full Text] [Related]
12. Neurobehavioral syndrome induced by H2-receptor blocker withdrawal: possible role of prolactin.
Rampello L; Raffaele R; Nicoletti G; Le Pira F; Vecchio I; Malaguarnera M; Drago F
Clin Neuropharmacol; 1997 Feb; 20(1):49-54. PubMed ID: 9037573
[TBL] [Abstract][Full Text] [Related]
13. [The H2-antagonist therapy withdrawal syndrome: the possible role of hyperprolactinemia].
Rampello L; Nicoletti G
Medicina (Firenze); 1990; 10(3):294-6. PubMed ID: 1981922
[TBL] [Abstract][Full Text] [Related]
14. Antisecretory drugs and gastric cancer.
Langman MJ
Br Med J (Clin Res Ed); 1985 Jun; 290(6485):1850-2. PubMed ID: 2860944
[No Abstract] [Full Text] [Related]
15. Outcome of pregnancy after first trimester exposure to H2 receptor antagonists.
Koren G; Zemlickis DM
Am J Perinatol; 1991 Jan; 8(1):37-8. PubMed ID: 1670987
[TBL] [Abstract][Full Text] [Related]
16. [H2 antagonists and the heart].
Corradini P; Zocchi M; Buonavia A
Minerva Med; 1986 Dec; 77(47-48):2209-15. PubMed ID: 2880317
[TBL] [Abstract][Full Text] [Related]
17. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
Thomas JM; Misiewicz G
Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
[No Abstract] [Full Text] [Related]
18. Hemodynamic effects of H2-receptor antagonists.
Iberti TJ
DICP; 1990 Nov; 24(11 Suppl):S35-7. PubMed ID: 1980182
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced parotitis.
Thompson DF
J Clin Pharm Ther; 1993 Aug; 18(4):255-8. PubMed ID: 7901230
[TBL] [Abstract][Full Text] [Related]
20. Confounding by indication?
Shapiro S
Epidemiology; 1997 Jan; 8(1):110-1. PubMed ID: 9116082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
